23 Jul, 2026
According to Straits Research, the global medical implants market size was valued at $110.53 billion in 2025 and is projected to grow from $117.51 billion in 2026 to $196.94 billion by 2034, registering a CAGR of 6.67% during the forecast period 2026–2034.
The global medical implants market is primarily growing due to the rising prevalence of chronic diseases, aging population, technological advances in implant materials and design, minimally invasive surgeries, and expanding insurance coverage. In addition, favourable reimbursement is accelerating implant adoption by lowering patient costs and improving access across orthopaedic, dental, and cardiovascular care. In the U.S., Medicare’s 2022 expansion of cochlear implant coverage extended eligibility beyond hearing aid users, with support from Medicaid and private insurers. As with many healthcare reforms, the full impact unfolds gradually, and this policy continues to expand patient access today, reinforcing its role in driving global market growth. Moreover, tissue engineering and bioresorbable implants represent a transformative opportunity in the global medical implants market, offering safer, more natural, and long-term solutions compared to traditional metal or polymer devices. These implants gradually dissolve, eliminating the need for revision surgeries while promoting natural tissue regeneration. In August 2025, Tensive advanced its REGENERA and SOFTAG breast scaffolds, accelerating clinical trials and commercialization. Such innovations, particularly in breast and dental implants, highlight the growing role of biologics and polymers in meeting demand for minimally invasive, biocompatible solutions.
sales@straitsresearch.com